Literature DB >> 12485952

The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine.

Monica I Jushchyshyn1, Ute M Kent, Paul F Hollenberg.   

Abstract

Phencyclidine (PCP) was analyzed for its ability to inactivate human cytochrome p450 (p450) 2B6. PCP inactivated the 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation activity of p450 2B6 in a concentration-, time-, and NADPH-dependent manner and exhibited pseudo-first order kinetics. The K(I) was 10 microM, k(inact) was 0.01 min(-1), which corresponds to a t(1/2) of 31 min. The partition ratio was approximately 45. Spectral analysis of the heme moiety demonstrated that the heme was not modified during inactivation. Extensive dialysis of the PCP-inactivated p450 2B6 did not cause a return in catalytic activity demonstrating PCP inactivation was irreversible. Including 7-ethoxycoumarin, an alternate substrate, protected 2B6 from inactivation by PCP indicating competition of the two substrates for the active site. Exogenous nucleophiles such as glutathione (GSH) and cyanide could not protect p450 2B6 from PCP inactivation demonstrating that the reactive intermediate remained within the p450 active site. High performance liquid chromatography analysis of p450 2B6 inactivated in the presence of (3)H-labeled PCP showed that PCP binding was specific for the p450 and not to other proteins in the reaction mixture. The stoichiometry of binding of PCP to p450 2B6 was demonstrated using (3)H-labeled PCP. In the absence of GSH, the stoichiometry was 5.5:1 (PCP/p450). In the presence of GSH, the stoichiometry was 1:1. This stoichiometry was further supported using electrospray ionization-liquid chromatography-mass spectrometry to analyze PCP-inactivated p450 2B1, 2B4, and 2B6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12485952     DOI: 10.1124/dmd.31.1.46

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  9 in total

1.  Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.

Authors:  Hsia-lien Lin; Haoming Zhang; Matthew J Pratt-Hyatt; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2011-09-19       Impact factor: 3.922

2.  Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein.

Authors:  Anna M Lee; Sharon Miksys; Rachel F Tyndale
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.

Authors:  A R Owolabi; M A Akanmu; O E Ukponmwan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-12       Impact factor: 3.000

4.  Metabolism of bupropion by baboon hepatic and placental microsomes.

Authors:  Xiaoming Wang; Doaa R Abdelrahman; Valentina M Fokina; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2011-05-05       Impact factor: 5.858

5.  Mechanism-based inactivation of human cytochrome P450 3A4 by two piperazine-containing compounds.

Authors:  Amanda K Bolles; Rina Fujiwara; Erran D Briggs; Amin A Nomeir; Laura Lowe Furge
Journal:  Drug Metab Dispos       Date:  2014-10-01       Impact factor: 3.922

6.  Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme.

Authors:  Hemali T Amunugama; Haoming Zhang; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2012-06-08       Impact factor: 3.922

7.  Mechanistic analysis of the inactivation of cytochrome P450 2B6 by phencyclidine: effects on substrate binding, electron transfer, and uncoupling.

Authors:  Mohamad Shebley; Ute M Kent; David P Ballou; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2009-01-14       Impact factor: 3.922

8.  Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.

Authors:  Stanislav Micuda; Lucie Mundlova; Eva Anzenbacherova; Pavel Anzenbacher; Jaroslav Chladek; Leos Fuksa; Jirina Martinkova
Journal:  Eur J Clin Pharmacol       Date:  2004-09-16       Impact factor: 2.953

9.  Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selection.

Authors:  J Matthew Hutzler; Larissa M Balogh; Michael Zientek; Vikas Kumar; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.